Evaluation of the functional impact of cancer-associated missense variants is more difficult than for protein-truncating mutations and consequently standard guidelines for the interpretation of sequence variants have been recently proposed. A number of algorithms and software products were developed to predict the impact of cancer-associated missense mutations on protein structure and function. Importantly, direct assessment of the variants using high-throughput functional assays using simple genetic systems can help in speeding up the functional evaluation of newly identified cancer-associated variants. We developed the web tool CRIMEtoYHU (CTY) to help geneticists in the evaluation of the functional impact of cancer-associated missense variants. Humans and the yeast Saccharomyces cerevisiae share thousands of protein-coding genes although they have diverged for a billion years. Therefore, yeast humanization can be helpful in deciphering the functional consequences of human genetic variants found in cancer and give information on the pathogenicity of missense variants. To humanize specific positions within yeast genes, human and yeast genes have to share functional homology. If a mutation in a specific residue is associated with a particular phenotype in humans, a similar substitution in the yeast counterpart may reveal its effect at the organism level. CTY simultaneously finds yeast homologous genes, identifies the corresponding variants and determines the transferability of human variants to yeast counterparts by assigning a reliability score (RS) that may be predictive for the validity of a functional assay. CTY analyzes newly identified mutations or retrieves mutations reported in the COSMIC database, provides information about the functional conservation between yeast and human and shows the mutation distribution in human genes. CTY analyzes also newly found mutations and aborts when no yeast homologue is found. Then, on the basis of the protein domain localization and functional conservation between yeast and human, the selected variants are ranked by the RS. The RS is assigned by an algorithm that computes functional data, type of mutation, chemistry of amino acid substitution and the degree of mutation transferability between human and yeast protein. Yeast Research, 2017, Vol. 17, No. 8 to yeast and, therefore, yeast functional assays will be more predictable. To validate the web application, we have analyzed 8078 cancer-associated variants located in 31 genes that have a yeast homologue. More than 50% of variants are transferable to yeast. Incidentally, 88% of all transferable mutations have a reliability score >0. Moreover, we analyzed by CTY 72 functionally validated missense variants located in yeast genes at positions corresponding to the human cancer-associated variants. All these variants gave a positive RS. To further validate CTY, we analyzed 3949 protein variants (with positive RS) by the predictive algorithm PROVEAN. This analysis shows that yeast-based functional assays will be more predictable for the variants with positive RS. We believe that CTY could be an important resource for the cancer research community by providing information concerning the functional impact of specific mutations, as well as for the design of functional assays useful for decision support in precision medicine.
INTRODUCTION
Owing to rapid advances in next-generation sequencing technologies, tens of thousands of disease-associated mutations and millions of single nucleotide polymorphisms have been identified in the human population (Abecasis et al. 2012) . The application of next-generation sequencing technology in cancer genomics has provided a lot of information about the presence of somatic mutations in all cancers and generated several databases collecting cancer genomics data (Chin et al. 2011) . The classification and the functional impact of cancer-associated somatic missense variants are more difficult to evaluate as compared with protein-truncating mutations and consequently standard guidelines for the interpretation of sequence variants have been recently proposed (Richards et al. 2015) . Evaluating the pathogenicity of missense mutations is a fundamental step in identifying variants associated with the disease (Thusberg, Olatubosun and Vihinen 2011; Salgado et al. 2016) . A number of variant interpretation predictors have been developed to predict the impact of missense mutations on protein structure and function including sequence-and structure-based approaches (Niroula and Vihinen 2016) . A number of in silico methods based on orthologous protein sequence alignments are available for predicting the influence of variants on protein activity. Examples include Sorting Intolerant From Tolerant (SIFT) and Polymorphism Phenotyping (PolyPhen; Ng and Henikoff 2001; Sunyaev et al. 2001) . These methods are based on the notion that phylogenetic conservation of protein sequence throughout evolution reflects the requirement for certain amino acids for protein activity. Moreover, a system to facilitate the comprehensive analysis of cancer-related missense variants by combining the 3D structure and the functional data from different database annotations has been proposed (Vazquez, Valencia and Pons 2015) . In addition, the performance evaluation of these predictive automated computational methods is rather variable (Hicks et al. 2011; Shihab et al. 2013) . Several software products have been proposed to predict the functional impact of somatic or germline mutations. Among them, CRAVAT, CHASM and SNVBox specifically predict the functional effect of missense mutations in order to prioritize for further analysis (Wong et al. 2011; Douville et al. 2013) .
Recently, a novel method for predicting disease severity has been proposed for the classification of amino acid substitutions associated with severe and less severe phenotypes (Niroula and Vihinen 2017a,b) . Notably, most of the time, genetic methods are not informative due to the rare frequency of the variant, which is, consequently, listed as 'of unknown significance' (a variant of unknown significance; VUS). This uncertainty is problematic as uninformative results may complicate the cancer risk assessment and affect the psychological state of carriers and relatives (Couch et al. 2008) . Alternative methods such as 'functional assays' have been developed to improve the VUS classification. As they do not directly assess cancer development but structural or functional modifications of the protein, they provide indirect evidence of variant pathogenicity (Goldgar et al. 2008) . A computational method has been developed to integrate results from functional assays in order to evaluate the clinical impact of VUS (Iversen et al. 2011) . Schematically, functional assays can be performed in biological or in vitro systems and with in silico methods (Couch et al. 2008; Tavtigian et al. 2008) . Functional assays rely on a phenotype observed for the wild-type protein that is altered by pathogenic but not neutral variants. Cancer-causing mutations in a tumor suppressor gene are expected to impair the protein's biological activity. The purpose of functional assays is not only to serve as independent classifiers of VUSs by assessing their influence on protein conformation, but also, more importantly, to correlate the biological function of the protein with the tumor suppression activity. The biological validity of a functional assay should be assessed at two levels, first by determining to what extent the assay relies on a natural function of the protein, but also by determining how this particular function contributes to tumor suppression. Importantly, direct assessment of the variants using high-throughput functional assays using simple genetic systems can help in speeding up the functional evaluation of newly identified cancer-associated variants (Ou et al. 2007; Andersen et al. 2012; Millot et al. 2012; Guidugli et al. 2014) .
Humans and the yeast Saccharomyces cerevisiae share thousands of protein-coding genes although they have diverged for a billion years (Douzery et al. 2004) . Therefore, construction of yeast strains with humanized genes can be helpful in evaluating the functional consequences of human genetic variants found in several diseases (Aggarwal and Brosh 2012; Hamza et al. 2015; Laurent et al. 2015) . Regardless of orthology, overexpression of cancer-related proteins such as p53, BRCA1 and BRCA2 has been used to develop yeast-based functional assays to identify pathogenic missense variants (Brachmann, Vidal and Boeke 1996; Inga et al. 1997; Caligo et al. 2009; Spugnesi et al. 2013; Guaragnella et al. 2014) . While researchers have been humanizing yeast for at least the past 30 years, the application of high-throughput and large scale yeast technologies to the field is relatively new. A substantial portion of conserved yeast and human genes perform much the same roles in both organisms, to an extent that the protein-coding DNA of a human gene can actually substitute for the yeast counterpart . Moreover, based on aligned amino acid sequences of orthologous yeast and human proteins, a number of researchers have opted to mutate native yeast proteins to match the human sequences at key positions. In particular, evolutionarily conserved residues are often important for protein function and show an elevated frequency of being involved in human diseases (Miller and Kumar 2001; Laurent et al. 2015) . This notion has led to the investigation of many yeast proteins while making substitutions in the context of their human counterparts. If a mutation at a specific amino acid residue of a human protein is associated with a disease phenotype, a similar substitution in the yeast orthologue may reveal its effect on the protein and at the organism level.
Classical examples of humanizing specific positions within native yeast genes, to study the functional impact of cancerrelated missense variants, are the pioneer work to predict the role of the human mismatch repair genes hPMS1, hMLH1 and hMSH2 in colon cancer (Strand et al. 1993; Shimodaira et al. 1998; Gammie et al. 2007) . Moreover, to evaluate the functional impact of rare missense variants of DNA double strand break repair gene RAD51 and RAD52, yeast strains carrying correspondent mutated alleles were constructed (Lee et al. 2015) . Recently, cancer-associated DNA polymerase δ variants have been modeled in yeast to investigate its effect in genome instability (Daee, Mertz and Shcherbakova 2010; Mertz et al. 2015) . In theory, it is more difficult to evaluate the functional impact of missense mutations than the effect of large deletions or frameshift mutations that presumably destroy protein function. Here, we presented a new web tool named CRIMEtoYHU (CTY; http://crimetoyhu.ifc.cnr.it/) that can be of great help to cancer geneticists in the evaluation of the functional impact of cancerassociated missense variants by setting up easy and fast functional assays in the simple eukaryote Saccharomyces cerevisiae and to assess the clinical impact of newly identified cancerassociated missense variants.
MATERIALS AND METHODS

Software architecture
CTY is a multi-tier application implemented in Python with Django Framework for the web-based front end. The presentation layer makes extensive use also of the Bokeh Library for interactive graphics and charts. The Bootstrap 3.0 framework with HTML5 and CSS complete the client-side user interface in compatibility mode with the most popular web browsers.
As shown in Fig. 1 , the CTY application layer performs a pipeline by filtering and processing data flows from different sources: (i) a local instance of the COSMIC database (Forbes et al. 2015) , preprocessed by data aggregations to optimize queries, (ii) the 'g:Profiler' and 'Ensembl' RESTful web services, and (iii) 'InterProScan'.
User interface
By an HTML form, the user must enter the name of the human gene to analyze and select one or more tumors from a list of primary sites from the COSMIC database (Forbes et al. 2015) . For each type of cancer, the associated mutations will be extracted and analyzed.
Moreover, the user can also add any other protein variants to be analyzed. Each mutation must be inserted into the query form according to syntax notation defined by the Human Genome Variation Society. 
Yeast orthologous and function conservation analysis
The existence of a yeast orthologue of the human gene is restrictive for the process implementation of mutations analysis. By the Ensembl RESTful web service, we interrogate the database to discover orthologous protein in S. cerevisiae and retrieve aligned sequences in Fasta format. If no yeast homologous gene is found, the process is aborted.
The conservation of protein domains and functions is not a limiting condition to continue the analysis, but it is highly discriminating for ranking the mutations in the yeast homologous gene.
Functional conservation analysis is performed via the Python API by g:Profiler, a webserver toolset for profiling of genes (Reimand et al. 2016) . It compares the profiles of human and yeast homologous genes and then reports the conserved functional domains between a human protein and its yeast orthologue. The analysis examines the information on biological processes, cellular components and molecular functions exploring Gene Ontology. It also examines the annotated pathways in the KEGG and Reactome databases. g:Profiler retrieves results with a P-value ≤0.05.
Analysis of transferability of mutations
A key point of the analysis concerns the assessment of the transferability of the human variants into yeast orthologous genes. The algorithm used by CTY explores the areas of conservation by aligning the two amino acid sequences and localizes the position of human mutations retrieved from the COSMIC database or submitted by the user.
In sequence alignment algorithms (both amino acids and nucleotides) a similarity value, dependent by the degree of conservation of the two sequences, is computed. The greater is the amino acid conservation between a yeast and human protein, the greater the numerical value of similarity. By using the BLO-SUM substitution matrix, which assigns to each possible pair of amino acids a value that indicates their degree of similarity, we obtain information on the probability that an amino acid is substituted with another during evolution (Henikoff and Henikoff 1992) . In this web tool, we have used the BLOSUM62 matrix, which provides for a conservation of amino acids greater than or equal to 62%.
After the alignment of the orthologous proteins, CTY identifies the position of mutations along the alignment and calculates the values of the replacement score for each variant on the basis of the BLOSUM matrix. In detail, given two amino acid sequences belonging respectively to the human protein (H) and its orthologue in yeast (Y) of length w and z respectively,
and given a set of mutations (v)
the protein sequences' alignment, of length n, and the position of the mutation m j ∈ M can be indicated as follows:
where m j,k indicates the jth mutation applied to the amino acid in the kth position of the human protein sequence, h i,k and y i, p indicate respectively the kth residue of the human protein sequence and the pth residue of the yeast protein sequence, both in the ith position of sequences alignment of length n, and k and p indicate the corresponding residue position in each protein and cannot be perfectly aligned because of different length due to the evolutionary distance of the sequences, as described in the alignment with the insertion of gaps.
After localization of the residues onto the alignment positions, for each pair (
and a mutation score value MS y,m = f MS (y i, p , m j, p ). All these score values are computed on the basis of the BLOSUM62 matrix applied to human and yeast residues and to the mutation type.
The score value AS h,y indicates the degree of similarity between the pairs of amino acids of the aligned proteins; the score value CS h,m indicates the degree of similarity between the residues in human wild-type and in the mutated protein; the value of the MS y,m score, instead, indicates how conservative will be the effect of the mutation on the yeast corresponding residues. According to the BLOSUM algorithm, for protein alignments, the conservation codes are: r when the amino acid pair is identical and the function is conserved r when the amino acid pair is different but the function is conserved r when the amino acid pair is different but the function is semi-conserved r when the amino acid pair is different with no conservation of function r when one amino acid is missing (presence of gap) with no conservation of function.
The evaluation of these score values will filter the mutations defining the transferability of mutations: if the alignment score AS h,y ≥ 0 and the conservation score CS h,m ≥ 0, conservation between human and yeast residues exists; therefore, mutation m can be transferred to the corresponding residue of the yeast protein.
Functional domains analysis
The sequence of amino acids from the yeast orthologue protein is analyzed through RESTful services running InterproScan of EBI (Quevillon et al. 2005) . The service identifies functional domains using 15 databases such as Prodom, PRINTS, PIRSF, PfamA, SMART, TIGRFAM, PrositeProfiles, HAMAP, PrositePatterns, SuperFamily, SFLD, Gene3D, CDD, MobiDBLite and coils.
The filtered occurrences of mutations, which enjoy the status of transferability mutation, will be located within the merged recognized domains.
Reliability score of conserved mutations
Due to a large set of human mutations transferred to yeast, we define a score value, named the reliability score (RS), to suggest which mutation has to be chosen to develop a more reliable functional assay. Data obtained in the previous step of the pipeline are processed to assign a weighted value of the RS to each variant, computing the degree of conservation of each mutation on the basis of the type of mutation, the alignment score, conservation score and mutation score values and the number of recognized domains for each location of variants under consideration. The greater the value of the RS, the higher will be the probability of affecting the function of a homologous protein. As depicted below, a cut-off value of 0.609 has been selected by the analysis of a receiver operating characteristic (ROC) curve in the performance assessment. However, a functional assay on yeast is mandatory to validate the suggested choice. Finally, the user can select the sequence of residues associated with the chosen humanized variant.
Performance assessment
All transferred mutations found in yeast were analyzed by the PROVEAN tool to predict the functional effect. We referred to them as the gold standard to compute values for true positive (TP), false negative (FN), true negative (TN) and false positive (FP), where TP and FN are, respectively, the numbers of correctly and incorrectly identified pathological variants and TN and FP are, respectively, the numbers of correctly and incorrectly identified neutral variants.
The sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), F-measure and Matthews correlation coefficient (MCC) were calculated for measuring the performance of our method, in accordance with parameters that are generally used in the description of bioinformatics predictors (Vihinen 2012; Lever, Krzywinski and Altman 2016) .
Sensitivity measures the ability to identify pathological (positive) variants and is defined as: Sensitivity = TP TP + FN Specificity measures the ability to identify neutral (negative) variants and is defined as:
Accuracy provides an overall view of the success rate of the predictor and is defined as:
Positive predictive value is the probability that a positive prediction corresponds to a pathogenic variant and is defined as:
Negative predictive value is the probability that a negative prediction corresponds to a neutral variant and is defined as:
The F-measure, in statistical analysis of binary classification, is a measure of a test's accuracy. It reaches its best value at 1 and worst at 0. The F-measure is defined as:
The MCC is considered a measure of the quality of binary classification. It returns a value between −1 and +1. A coefficient of +1 represents a perfect prediction, 0 no better than random prediction and −1 indicates total disagreement between prediction and observation. It is defined as:
We, also, performed an ROC analysis and computed the area under the curve (AUC) value. To maximize sensitivity and specificity we applied the Youden index to the ROC curve, permitting us to identify the best cut-off value (cut-off = 0.609). The Youden index is computed as:
RESULTS
CRIMEtoYHU
Because genetic testing for disease syndromes such as cancer has become increasingly common in clinical practice, the number of VUSs will continue to rise and the need for methods allowing determination of the disease relevance of the VUSs will increase. We developed a novel web application named CRIMEtoYHU (Choosing the RIght cancer-associated Mutation for Evaluation to Yeast HUmanization; CTY) that simultaneously finds yeast homologous genes and identifies the corresponding missense variant. CTY aims at guiding the user in the selection of somatic mutations associated with human tumors that can be translated in a yeast model organism and to assess its functional impact at the simpler organism level. Therefore, this tool is useful to develop functional yeast-based assays in order to help in the evaluation of the pathogenicity of the identified variants. CTY is a multi-tier web application that integrates, processes and annotates data streams from different sources, in particular data flows from databases and the RESTful web services; it utilizes several providers in order to retrieve information from databases; the pipeline steps integrate data to assess the transferability of human mutations to yeast genes (Fig. 1) . CTY analyzes newly identified mutations or retrieves somatic mutations reported in the COSMIC database, provides information about the functional conservation between yeast and human and shows the mutation distribution in human genes. COSMIC is the world's largest and one of the most comprehensive resource for exploring the impact of somatic mutations in human cancer (Forbes et al. 2015) . The complete list of cancer-associated variants in a specific gene is provided by the web tool. CTY analyzes also newly found mutations and aborts when no yeast homologue is found. CTY evaluates the alignment of amino acid sequence of human to yeast genes and localizes the mutations in the yeast protein domains (Fig. 2) . Moreover, the web tool generates a list of transferable mutations for the specific cancerassociated gene (Fig. 2) . Then, on the basis of the protein domain localization and functional conservation between yeast and human, the selected variants are ranked by the reliability score (RS). The RS is given to yeast mutations on the basis of the protein domain localization and the selected variants are ranked by the RS, which is determined by an algorithm taking into account the amino acid conservation and alignment ( Fig. 3A  and B) . The RS is assigned by an algorithm that computes functional data, type of mutation, chemistry of amino acid substitution and the degree of mutation transferability between human and yeast protein. Cancer-associated variants giving a positive RS are highly transferable to yeast and, therefore, yeast functional assays will be more predictable.
CTY application and validation
CTY validation was evaluated as follows. We first determined how many somatic mutations found in breast, colon and ovary cancer reported in the COSMIC database have a yeast orthologue. The complete list of genes found mutated in breast, ovary and colon cancer are reported as Supplementary Data S1-S3 and Supplementary Tables S1-S3. For each gene, the number of total variants and the number of the variant predicted as pathogenic is shown (Supplementary Data S1-S3 and Supplementary Tables S1-S3). We retrieved from the COSMIC database also small in-frame deletions/insertions, and nonsense mutations. Functional analysis showed a high level of conservation between yeast and humans confirming the strength of yeast as a model to study the functional impact of human genes (Supplementary Data S4a, b, c and Supplementary Table S4a, b, c) .
Among all the somatic mutations reported, the missense variants that are due to one amino acid substitution are the most represented for all three types of cancer (Supplementary Data S5  and Supplementary Table S5) .
In order to test the web application, we have analyzed a total of 8078 cancer-associated variants located in 31 genes that are present in most commercial multigene panels and have been chosen since they have yeast homologues ( Table 1 . Reliability score and transferability of missense variants located in 31 human genes. A total of 8078 mutations located in 31 genes having a yeast counterpart were selected from the COSMIC database. Total number of considered mutations (CM) and transferable mutations (TM) is reported. Reliability score (RS) values were determined by evaluating the functional conservation as reported in 'Materials and methods'. RS ≥ 0 is defined as highly transferable mutations (RM). and 48.6% have a reliability score >0. Incidentally, 88% of all transferable mutations have a reliability score >0 (Table 1) . Moreover, we analyzed by CTY 72 functionally validated missense variants located in yeast genes at positions corresponding to the human cancer-associated variants. All these variants gave positive reliability score (Supplementary Data S6 and Supplementary  Table S6 ). For a more complete validation, we decided to use the PROVEAN software tool that predicts the functional effect of single or multiple amino acid substitutions, insertions and deletions (Choi and Chan 2015) . We thought that assessment of how pathogenic and neutral variants are predicted by PROVEAN could give important indications on the reliability of the 'yeast based-functional assays' to be developed. For each element belonging to a set of 31 human genes, CTY has run using subsets of known variants retrieved from the COSMIC database. We found 4458 transferable mutations of 8078 human variants (Table 1) .
RS
However, the PROVEAN algorithm's design discarded nonsense substitution variants; thus the predictive tool analyzed 3949 of the 4458 variants of yeast proteins that were found orthologous to human genes. By PROVEAN analysis, we obtained two sets of data corresponding to pathological and neutral variants. We referred to them as the gold standard.
As for all binary prediction test problems, we had to select a threshold value for discriminating pathological from neutral predictive values. To obtain the best cut-off, we used RS given by CTY and PROVEAN data to compute the ROC, and calculated the Youden index and AUC (Fig. 4) . The Youden index, defined as J = Sensitivity + Specificity − 1, maximizes the difference between sensitivity and false negative rate (FNR = 1 − Specificity).
The AUC is an effective and combined measure of sensitivity and specificity that summarizes the validity of the predictive test: an AUC equal to 1 represents an ideal test and an AUC equal to 0.5 represents a worthless test. We calculated an AUC value of 0.881 as reported in Fig. 4 . Moreover, the optimal cut-off point is computed by maximizing the Youden index across various cutoff points and is equal to 0.609.
To further validate CTY, we calculated the classification metrics by determining number of TP, FP, TN and FN variants that came out from PROVEAN and CTY. We performed this analysis by using the best found cut-off and we obtained the confusion matrix as depicted in Table 2 . Furthermore, the sensitivity, specificity, accuracy, PPV, NPV, F-measure and MCC were calculated for measuring CTY performance (Table 3) . We obtained high statistically significant values of sensitivity, specificity and accuracy that consequently generate a high percentage of PPV and NPV (Table 3) . Importantly, positive MCC and F-values were obtained from the CTY data suggesting that yeast-based functional assays to be developed for characterizing mutations that are highly transferable (positive RS) may have strong prediction.
DISCUSSION
Due to next generation sequencing technology both rare and common sequence variants within individual humans have been routinely identified. There is now an urgent need to characterize those genetic variations with the greatest potential to impact human health. Cancer-associated germline variants are often classified by a method integrating association with the disease of interest in cases and controls, co-segregation with the disease in families, family history analysis, the cooccurrence of the variant in trans with a pathogenic variant, population frequency, functional assay and deleteriousness predictions (Goldgar et al. 2004) . Experimental assessment of variant function in human cells is hampered by inefficient allele replacement technology and by the presence of paralogues with overlapping functions, making complementation testing in 'humanized' model organisms such as yeast an attractive alternative (Sun et al. 2016) . Ideally, the functional effect of human genetic variants would be evaluated in human cells. Unfortunately, it can be challenging to identify a phenotype in human cells that is strong enough to quantitatively evaluate functional variation (Hart et al. 2014) . Very recently, a panel of 26 yeast-based functional complementation assays was developed and exploited to measure the impact of 179 variants (101 disease-and 78 non-disease-associated variants) from 22 human disease genes. Notably, experimental functional assays in a 1-billion-year diverged model organism can identify pathogenic alleles with significantly higher precision and specificity than current computational methods (Sun et al. 2016) . Therefore, yeast could be an excellent platform to set up functional assays to quickly evaluate the impact of genetic variants on human diseases such as cancer. For these reasons, we developed CTY as new web tool that could be very useful for fast and easy development of yeast-based functional assays to evaluate the clinical impact of cancer-related missense variants. CTY is not a prediction algorithm to be used to classify a cancerassociated variant but a new bioinformatics tool that may be helpful to evaluate the functional impact of a newly identified variant. When a new missense variant is identified in cancer, the following points have to be taken into account for making the yeast strain carrying the correspondent variants: the presence of the yeast homologue, gene function and protein domain conservation. CTY implements a computation workflow that can be used to explore, visualize and analyze mutations across genes and tumor types in order to choose the most reliable mutations. Moreover, CTY significantly speeds up the analysis because it simultaneously finds yeast homologous genes and identifies the corresponding yeast variants by aligning human and yeast sequences and comparing protein domains. Notably, this web tool determines the transferability of human variants to yeast counterparts by assigning a reliability score that may be predictive for the validity of the functional assay. CTY analyzes newly identified mutations or retrieves somatic mutations reported in the COSMIC database, provides information about the functional conservation between yeast and human and shows the mutation distribution in human genes. CTY analyzes also newly found mutations and aborts when no yeast homologue is found. Importantly, on the basis of the protein domain localization and functional conservation between yeast and human, the selected variants are ranked by the reliability score. Computational methods for predicting variant pathogenicity generally require a training set of pathogenic and non-pathogenic variants; to validate CTY, we determined the classification metrics and we calculated a cut-off value in the ROC curve. This analysis shows that cancer-related mutations giving a positive RS are highly transferable to yeast and, therefore, yeast functional assays will be more predictable. Therefore, CRY could be an important resource for the cancer research community by providing information concerning functional impact of specific mutations, as well as for the design of functional assays useful for decision support in precision medicine.
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